Search Results - Alexa B. Kimball

  • Showing 1 - 12 results of 12
Refine Results
  1. 1

    Update on biologic safety for patients with psoriasis during pregnancy by Martina L. Porter, Stephen J. Lockwood, Alexa B. Kimball

    Get full text
    Article


  2. 2

    Erythrocyte sedimentation rate, rather than C-reactive protein, may be the preferred biomarker for hidradenitis suppurativa by Ruby S. Gibson, MD, Martina L. Porter, MD, Alexa B. Kimball, MD, MPH

    Published in JAAD International (2022-09-01)
    Get full text
    Article


  3. 3

    Placebo responders with moderate-to-severe hidradenitis suppurativa experience declines in inflammation as measured by C-reactive protein: a post hoc analysis of two double-blinded... by Simon J. Gunter, MPhil, Martina L. Porter, MD, Alexa B. Kimball, MD, MPH

    Get full text
    Article


  4. 4

    Assessing the Impact of Improvements in PASI and Itch Scores on Patients’ Quality of Life in the Treatment of Psoriasis by Gil Yosipovitch, Yan Dong, Russel Burge, Baojin Zhu, David Shrom, Alexa B. Kimball

    Published in Acta Dermato-Venereologica (2019-07-01)
    Get full text
    Article


  5. 5

    Prednisone and amoxicillin/clavulanic acid for the treatment of hidradenitis suppurativa flares: a prospective observational study by Ruby S. Gibson, MD, Corey L. Snyder, BSA, Martina L. Porter, MD, Alexa B. Kimball, MD, MPH

    Get full text
    Article


  6. 6

    Evaluating minority representation across health care settings in hidradenitis suppurativa and psoriasis by Charlotte Greif, MD, Ruby S. Gibson, MD, Alexa B. Kimball, MD, MPH, Zachary E. Holcomb, MD, Martina L. Porter, MD

    Get full text
    Article


  7. 7

    Data wobbles in hidradenitis suppurativa clinical trials and potential contributing factors: a retrospective review by Corey L. Snyder, MD, Ruby S. Gibson, MD, Stella X. Chen, MD, Martina L. Porter, MD, Alexa B. Kimball, MD, MPH

    Get full text
    Article


  8. 8

    Burden of Hidradenitis Suppurativa: A Systematic Literature Review of Patient Reported Outcomes by Alexa B. Kimball, Joslyn Kirby, John R. Ingram, Tanja Tran, Ingrid Pansar, Valerie Ciaravino, Damon Willems, Anne-Mary Lewis-Mikhael, Vanita Tongbram, Amit Garg

    Published in Dermatology and Therapy (2024-01-01)
    Get full text
    Article


  9. 9

    Efficacy and Safety of Risankizumab for the Treatment of Hidradenitis Suppurativa: A Phase 2, Randomized, Placebo-Controlled Trial by Alexa B. Kimball, Errol P. Prens, Thierry Passeron, Emanual Maverakis, Irina Turchin, Stefan Beeck, Leonidas Drogaris, Ziqian Geng, Tianyu Zhan, Izabella Messina, Falk G. Bechara

    Published in Dermatology and Therapy (2023-03-01)
    Get full text
    Article


  10. 10

    Treatment of hidradenitis suppurativa resolves associated hematologic abnormalities by Peyton C. Morss-Walton, BA, Charlotte Greif, BA, Zachary E. Holcomb, MD, Prerna Salian, MPH, Tuyen Yankama, MPH, Diana Kim, BA, Martina L., Porter, MD, Alexa B. Kimball, MD, MPH

    Get full text
    Article


  11. 11

    Long-Term Effectiveness of Dupilumab in Patients with Atopic Dermatitis: Results up to 3 Years from the RELIEVE-AD Study by Alexa B. Kimball, Dimittri Delevry, Min Yang, Chien-Chia Chuang, Zhixiao Wang, Gaëlle Bégo-Le-Bagousse, Bruno Martins, Eric Wu, Brad Shumel, Jessie Wang, Debra Sierka, Jingdong Chao, Bruce Strober

    Published in Dermatology and Therapy (2023-08-01)
    Get full text
    Article


  12. 12

    Assessing Long-Term Pain Reduction with Secukinumab in Moderate to Severe Hidradenitis Suppurativa: A Post Hoc Analysis of the SUNSHINE and SUNRISE Phase 3 Trials by John R. Ingram, Jacek C. Szepietowski, Lukasz Matusiak, Georgios Kokolakis, Magdalena B. Wozniak, Christine-Elke Ortmann, Angela Llobet Martinez, Shoba Ravichandran, Nicolas Thomas, Ivette Alarcon, Christelle C. Pieterse, Maryam Shayesteh Alam, Dimitrios Ioannides, Alexa B. Kimball

    Published in Dermatology and Therapy (2025-05-01)
    Get full text
    Article


Search Tools: